Effects of natural eggshell membrane (NEM) on cytokine production in cultures of peripheral blood mononuclear cells: Increased suppression of tumor necrosis factor-α levels after in vitro digestion

Journal of Medicinal Food

Volumn 15, Issue 4, 2012, Pages 360-368

  Benson, Kathleen F ^a   Ruff, Kevin J ^b   Jensen, Gitte S ^a  

^a NIS Labs   (United States)

^b ESM Technologies LLC   (United States)

Author keywords

cytokines; human; immunity; in vitro digestion; lymphocyte; natural eggshell membrane; natural product; peripheral blood mononuclear cells; Th1 Th2; tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EGG SHELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; MOLECULAR INTERACTION; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL PROLIFERATION; CELLS, CULTURED; EGG SHELL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; PHYTOHEMAGGLUTININS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

PHYTOLACCACEAE;

EID: 84859058191     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2011.0197     Document Type: Article

References (24)

1. Gonzalez EA: The role of cytokines in skeletal remodeling: possible consequences for renal osteodystrophy. Nephrol Dial Transplant 2000;15:945-950.
2. Komano Y, Nanki T, Hayashida K, Taniguchi K, Miyasaka N: Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res Ther 2006; 8:R152.
3. Tsutsumi H, Tanaka T, Ohashi N, Masuno H, Tamamura H, Hiramatsu K, Araki T, Ueda S, Oishi S, Fujii N: Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents. Biopolymers 2007;88:279-289.
4. Santiago B, Baleux F, Palao G, Gutierrez-Canas I, Ramirez JC, Arenzana-Seisdedos F, Pablos JL: CXCL12 [SDF-1] is displayed by rheumatoid endothelial cells through its basic amino-terminal motif on heparan sulfate proteoglycans. Arthritis Res Ther 2006;8:R43.
5. Ruff KJ, Devore DP, Leu MD, Robinson MA: Eggshell membrane: a possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies. Clin Interv Aging 2009;4:235-240.
6. Ruff KJ, Winkler A, Jackson RW, DeVore DP, Ritz BW: Eggshell membrane in the treatment of pain and stiffness from osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled clinical study. Clin Rheumatol 2009;28:907-914.
7. Wong M, Hendrix MJC, von der Mark K, Little C, Stern R: Collagen in the egg shell membranes of the hen. Dev Biol 1984;104:28-36.
8. Baker JR, Balch DA: A study of the organic material of hen'segg shell. Biochem J 1962;82:352-361.
9. Long FD, Adams RG, DeVore DP, inventors; New Life Resources, LLC, assignee: Preparation of hyaluronic acid from eggshell membrane. U.S. Patent 6,946,551. September 20, 2005.
10. Picard J, Paul-Gardais A, Vedel M: Sulfated glycoproteins from egg shell membranes and hen oviduct. Isolation and characterization of sulfated glycopeptides. Biochim Biophys Acta 1973;320: 427-441.
11. Yun S, Habicht J-P, Miller DD, Glahn RP: An in vitro digestion/ Caco-2 cell culture system accurately predicts the effects of ascorbic acid and polyphenolic compounds on iron bioavailability in humans. J Nutr 2004;134:2717-2721.
12. Boyer J, Brown D, Liu RH: In vitro digestion and lactase treatment influence uptake of quercitin and quercetin glucoside by the Caco-2 cell monolayer. Nutr J 2005;4:1-15.
13. Toor RK, Savage GP, Lister CE: Release of antioxidant components from tomatoes determined by an in vitro digestion method. Int J Food Sci Nutr 2009;60:119-129.
14. Jensen GS, Benson KF, Carter SG, Endres JR: GanedenBC30 cell wall and metabolites: anti-inflammatory and immune modulation effects in vitro. BMC Immunol 2010;11:15.
15. Sakkas L, Platsoucas C: The role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum 2007;56:409-424.
16. Attur M, Belitskaya-Lévy I, Oh C, Krasnokutsky S, Greenberg J, Samuels J, Smiles S, Lee S, Patel J, Al-Mussawir H, McDaniel G, Kraus VB, Abramson SB: Increased interleukin-1b gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum 2011;63:1908-1917.
17. Börjeson J, Reisfeld R, Chessin LN, Welsh PD, Douglas SD: Studies on human peripheral blood lymphocytes in vitro. I. Biological and physicochemical properties of the pokeweed mitogen. J Exp Med 1966;124:859-872.
18. Chessin LN, Börjeson J, Welsh PD, Douglas SD, Cooper HL: Studies on human peripheral blood lymphocytes in vitro. II. Morphological and biochemical studies on the transformation of lymphocytes by pokeweed mitogen. J Exp Med 1966;124:873-884.
19. de Vries E, Lafeber GJ, van der Weij JP, van Buijsen AC, Leijh PC, Cats A: Pokeweed-mitogen induced lymphocyte proliferation: the effect of stimulation on mononuclear phagocytic cells. Immunology 1980;40:177-182.
20. Weksler ME, Kuntz MM: Synergy between human T and B lymphocytes in their response to phytohaemagglutinin and pokeweed mitogen. Immunology 1976;31:273-281.
21. Hammarström L, Bird AG, Britton S, Smith CI: Pokeweed mitogen induced differentiation of human B cells: evaluation by a protein A haemolytic plaque assay. Immunology 1979;38:181-189.
22. Jensen GS, Poppema S, Mant MJ, Pilarski LM: Transition in CD45 isoform expression during differentiation of normal and abnormal B cells. Int Immunol 1989;1:229-236.
23. Greaves M, Janossy G, Doenhoff M: Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens. J Exp Med 1974;140:1-18.
24. Hochberg MC, Lebwohl MG, Plevy SE, Hobbs KF, Yocum DE: The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin Arthritis Rheum 2005;34: 819-836.